Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: J Manag Care Spec Pharm. 2015 Apr;21(4):346–352. doi: 10.18553/jmcp.2015.21.4.346

Table.

Summary of potential challenges to provision of MTM plus PGx testing service by community pharmacists.

  1. Timing of and Access to PGx Testing

    • Timing PGx testing for making optimal drug decisions

    • Access to PGx test results done in various clinical care settings

    • Ability of pharmacists to order PGx testing

  2. Extended MTM Sessions

    • Pharmacist time constraints in community practice

    • Uncertain added time needed for Initial and follow-up session needed to introduce testing/discuss test results

    • Uncertain feasibility of discussing PGx testing by phone versus face-to-face

  3. Information Technology

    • Potentially limited access to patient’s electronic health record

    • Need to integrate PGx test information into health IT tools for MTM

  4. Training & Workforce

    • Limited PGx education in pharmacy curriculum

    • Need for continuing education as PGx field grows

  5. Standards-Setting

    • Development of standards for integrating PGx testing into MTM practice to provide consistent and documentable added value

    • Consideration of pharmacist liability

  6. Reimbursement

    • Obtaining adequate reimbursement for MTM plus PGx testing service